Is the Chronic Care Model Integrated Into Research Examining Culturally Competent Interventions for Ethnically Diverse Adults With Type 2 Diabetes Mellitus? A Review

2015 ◽  
Vol 38 (4) ◽  
pp. 435-463 ◽  
Author(s):  
Marie Dauvrin ◽  
Vincent Lorant ◽  
William d’Hoore
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Chronic Care Model ◽  
Chronic Care ◽  
Ethnically Diverse ◽  
Culturally Competent ◽  
Care Model

scholarly journals The chronic care model for type 2 diabetes: a systematic review

2016 ◽  
Vol 8 (1) ◽  
Author(s):  
Deise Regina Baptista ◽  
Astrid Wiens ◽  
Roberto Pontarolo ◽  
Lara Regis ◽  
Walleri Christine Torelli Reis ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Chronic Care Model ◽  
Chronic Care ◽  
Care Model

scholarly journals Effectiveness of the Chronic Care Model in Type 2 Diabetes Management in a Community Health Service Center in China: A Group Randomized Experimental Study

2019 ◽  
Vol 2019 ◽  
pp. 1-12 ◽  
Author(s):  
Jing-Xia Kong ◽  
Lin Zhu ◽  
Hong-Mei Wang ◽  
Ying Li ◽  
An-Ying Guo ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Health Behaviors ◽  
Chronic Care Model ◽  
Chronic Care ◽  
Intervention Group ◽  
Care Model ◽  
Model Based

Objective. The Chronic Care Model, based on core elements of team-centered care in chronic diseases, has widely been accepted. This study was aimed at evaluating the effectiveness of the Chronic Care Model in type 2 diabetes management. Methods. A group randomized experimental study was conducted. Twelve communities of the Zhaohui Community Health Service Center in Hangzhou, China, were randomly assigned into an intervention group (n=6) receiving the Chronic Care Model-based intervention and a control group (n=6) receiving conventional care. A total of three hundred patients, twenty-five for each community, aged ≥18 years with type 2 diabetes for at least 1-year duration, were recruited. Data of health behaviors, clinical outcomes, and health-related quality of life (Short-Form 36-item questionnaire) were collected before and after a 9-month intervention and analyzed using descriptive statistics, t-test, chi-square test, binary logistic regression, and linear mixed regression. A total of 258 patients (134 in intervention and 124 in control) who completed the baseline and follow-up evaluations and the entire intervention were included in the final analyses. Results. Health behaviors such as drinking habit (OR=0.07, 95% CI: 0.01, 0.75), physical activity (OR=2.92, 95% CI: 1.18, 7.25), and diet habit (OR=4.30, 95% CI: 1.49, 12.43) were improved. The intervention group had a remarkable reduction in glycated hemoglobin (from 7.17% to 6.60%, P<0.001). The quality of life score changes of the role limitation due to physical problems (mean=9.97, 95% CI: 3.33, 16.60), social functioning (mean=6.50, 95% CI: 2.37, 10.64), role limitation due to emotional problems (mean=8.06, 95% CI: 2.15, 13.96), and physical component summary score (mean=3.31, 95% CI: 1.22, 5.39) were improved in the intervention group compared to the control group. Conclusion. The Chronic Care Model-based intervention helped improve some health behaviors, clinical outcomes, and quality of life of type 2 diabetes patients in China in a short term.

scholarly journals Effectiveness of the introduction of a Chronic Care Model-based program for type 2 diabetes in Belgium

2010 ◽  
Vol 10 (1) ◽  
Author(s):  
Patricia Sunaert ◽  
Hilde Bastiaens ◽  
Frank Nobels ◽  
Luc Feyen ◽  
Geert Verbeke ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Care Model ◽  
Chronic Care ◽  
Care Model ◽  
Model Based

Impact of a chronic care model based on patient empowerment on the management of Type 2 diabetes: effects of the SINERGIA programme

2011 ◽  
Vol 28 (6) ◽  
pp. 724-730 ◽  
Author(s):  
N. Musacchio ◽  
A. Lovagnini Scher ◽  
A. Giancaterini ◽  
L. Pessina ◽  
G. Salis ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Care Model ◽  
Chronic Care ◽  
Patient Empowerment ◽  
Care Model ◽  
Model Based

scholarly journals Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia

2021 ◽  
Vol 12 ◽  
pp. 204062232110425
Author(s):  
Manal Faleh AlMutairi ◽  
Ayla M. Tourkmani ◽  
Alian A. Alrasheedy ◽  
Turki J. ALHarbi ◽  
Abdulaziz M. Bin Rsheed ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Incremental Cost ◽  
Diabetes Care ◽  
Hba1c Level ◽  
Care Model ◽  
Traditional Care

Background and aim: Telemedicine could be used to provide diabetes care with positive clinical outcomes. Consequently, this study evaluated the cost-effectiveness of telemedicine for patients with uncontrolled type 2 diabetes mellitus (i.e. HbA1c >9). Patients and methods: This was a retrospective chart review of patients with uncontrolled type 2 diabetes attending an outpatient integrated care clinic. The study consisted of two arms, namely a telemedicine care model and a traditional care model with 100 patients in each. The clinical effectiveness (i.e. reduction in HbA1c) and the total cost in both arms were determined, and the incremental cost-effectiveness ratio was calculated. This study adopted propensity score matching. Results: The patients in the telemedicine care model had a mean reduction in their HbA1c level of 1.82 (95% CI = 1.56–2.09, p < 0.001), while those in the traditional care model had a mean reduction of 1.54 (95% CI = 1.23–1.85, p < 0.001). Consequently, the incremental effect was 0.28 (95% CI = −0.194 to 0.546). The mean total costs were SAR 4819.76 (US$1285.27) and SAR 4150.69 (US$1106.85) for patients in the telemedicine and traditional care models, respectively. Consequently, the incremental cost was SAR 669.07 (US$178.42) [95% CI = SAR 593.7 (US$158.32)–SAR 1013.64 (US$270.30)]. The ICER was estimated to be SAR 2372.52 (US$632.67) per 1% reduction in the level of HbA1c. Moreover, the telemedicine care model resulted in a higher cost and better outcome (i.e. reduction in the HbA1c level) with an 81.80% confidence level. Conclusion: Telemedicine care is cost-effective in managing type 2 patients with poorly controlled diabetes. Consequently, we believe that telemedicine care can be further expanded and incorporated into routine diabetes care.

Sign in / Sign up

Export Citation Format

Share Document